How Brella^® Works

To learn more about the science behind the Brella^® SweatControl Patch and Candesant’s patented targeted alkali thermolysis (TAT) technology, based on the scientific principle that thermal energy is generated when sodium comes in contact with water,^2,3 please click play on the video below.

Clinical Results

Brella is proven to achieve key efficacy endpoints, including significant reductions in HDSS^* and GSP,^** with significant improvements in Quality of Life⁴

The majority of Brella-treated patients experienced

50%

or greater reduction in sweat
production based on GSP⁴

HDSS* and GSP** Efficacy Endpoints

(at 4 weeks post-treatment)

Percent of Participants or

Gravimetric Sweat Production (GSP)

Primary Endpoint: Percent of participants achieving HDSS 1 or 2

Percent of participants achieving 2 points or greater improvement in HDSS

Percent of participants achieving 50% or greater reduction in gravimetric sweat production (GSP)

Mean reductions in GSP (mg produced in 5 min.)

Level of Bother and Impact of Sweat

(at 4 weeks post-treatment)

Reductions in level of Bother and
Impact on Daily Activities (5-point scale)

Reductions in sweat level of

Bother (5-point scale)

Reductions in sweat level of Impact on Daily Activities (5-point scale)

*HDSS- Hyperhidrosis Disease Severity Scale

**GSP- Gravimetrio Sweat Production

64%

of patients, after one Brella treatment, indicated that sweat never or sometimes interfered with daily activities⁴

64%

of patients, after one Brella treatment, indicated that sweat never or sometimes interfered with daily activities⁴

LASTING
RESULTS

48% and 43% of Brella-treated patients maintained reduced underarm sweating at weeks 14 and 16, respectively⁴

LASTING RESULTS

48% and 43% of Brella-treated patients maintained reduced underarm sweating at weeks 14 and 16, respectively⁴

QUALITY
OF LIFE

Brella is proven to significantly reduce excessive underarm sweat production and its negative impact on quality of life, including taking multiple showers per day, frequently changing shirts, and avoiding social situations. Brella also significantly reduces frustration and embarrassment and improves confidence.⁵

QUALITY OF LIFE

Brella was well tolerated. All adverse events were mild or moderate and transient. 78% of Brella-treated subjects reported no adverse events. 22% of Brella-treated subjects reported mild to moderate adverse events, such as mild irritation and redness, that mostly resolved within 2 weeks.⁴

Brella-treated patients experienced a significant physical and emotional improvement in quality of life⁵

SAHARA 7 Sweat Stressors: Negative Impact of Sweat on Daily Quality of Life (QoL) & Positive Impact of Brella™ at 4 and 12 Weeks

Before Brella Treatment

(Baseline)

4 weeks after Brella

(Brella patients improved)

12 weeks after Brella

(Brella patients improved)

Seven Questions from the SAHARA Clinical Study designed to assess the impact of sweating on both physical activities and psycho-social factors

It’s an excellent treatment option for patients with excessive underarm sweat.

— Larry Green, MD, FAAD | Aesthetic Dermatology Center

Treatment Overview

The Brella SweatControl Patch offers your patients a single-use, disposable, in-office treatment that’s quick, comfortable, non-invasive, needle-free with no downtime, and can easily fit into current aesthetic treatment regimens.

Patients report seeing results within a few days after receiving a single treatment.

The Brella ProcedureEasy as 1, 2, 3!

Clean, Dry, and Apply¹

Clean both axillae and examine to confirm they are free from any skin conditions.

Apply the Patch to a clean and dried underarm, smoothing to ensure full contact.

Patch Application & Removal¹

Gently massage the back of the Patch during treatment with gloved fingers. Treatment time depends on how much and how much and how quickly the patient sweats, so more sweat may require less treatment time. The goal is to treat to tolerability, so it is critical to continuously ask your patient how they are feeling. If your patient reports feeling a burn or burning sensation, an “ouch”, or a pain level of 7 or higher out of 10, immediately remove the patch and begin the deactivation process. After Deactivating the Patch (per steps below), clean the patient’s underarm. Repeat the process with a new Patch for the second underarm.

Deactivate and Dispose¹

Follow the Deactivation Kit steps to properly deactivate and dispose of the used Patches.

See Instructions for Use for complete treatment process.

Cheerful Blonde Woman Pointing to the form

Sign up to learn more and to reserve your spot to add Brella^® to your practice

References

1)	For complete prescribing information, see device instructions for use.
2)	Kaufman J, Green JB, Cazzaniga A, Canty DJ, Tims E, Waugh J. A Pilot Study of the Safety and Effectiveness of a Novel Device in Subjects With Axillary Hyperhidrosis. Dermatol Surg. 2022;48(11):1220-1225. doi:10.1097/DSS.0000000000003598.
3)	https://candesant.com/patents/
4)	Glaser DA, Green L, Kaminer M, Smith S, Pariser D. Outcomes from the SAHARA Clinical Study on the TAT Patch for Excessive Axillary Sweating or Primary Axillary Hyperhidrosis (abstract). Late-breaking oral presentation at: American Academy of Dermatology annual meeting; March 17-21 (presented March 18, 10:10 am CT), 2023; New Orleans, Louisiana.
5)	Jacob C, Green L. Quality of Life Improvement shown during SAHARA Clinical Study on the TAT Patch for Excessive Axillary Sweating or Primary Axillary Hyperhidrosis. Presentation abstract for Cosmetic Boot Camp (CBC) conference, June 22-25, 2023, Aspen, Colorado.

Cart

Your cart is empty

Clinical Results

Brella is proven to achieve key efficacy endpoints, including significant reductions in HDSS^* and GSP,^** with significant improvements in Quality of Life⁴

The majority of Brella-treated patients experienced

50%

or greater reduction in sweat
production based on GSP⁴

HDSS* and GSP** Efficacy Endpoints

(at 4 weeks post-treatment)

Percent of Participants or

Gravimetric Sweat Production (GSP)

Primary Endpoint: Percent of participants achieving HDSS 1 or 2

Percent of participants achieving 2 points or greater improvement in HDSS

Percent of participants achieving 50% or greater reduction in gravimetric sweat production (GSP)

Mean reductions in GSP (mg produced in 5 min.)

Level of Bother and Impact of Sweat

(at 4 weeks post-treatment)

Reductions in level of Bother and
Impact on Daily Activities (5-point scale)

Reductions in sweat level of

Bother (5-point scale)

Reductions in sweat level of Impact on Daily Activities (5-point scale)

*HDSS- Hyperhidrosis Disease Severity Scale

**GSP- Gravimetrio Sweat Production

64%

of patients, after one Brella treatment, indicated that sweat never or sometimes interfered with daily activities⁴

64%

of patients, after one Brella treatment, indicated that sweat never or sometimes interfered with daily activities⁴

LASTING
RESULTS

48% and 43% of Brella-treated patients maintained reduced underarm sweating at weeks 14 and 16, respectively⁴

LASTING RESULTS

48% and 43% of Brella-treated patients maintained reduced underarm sweating at weeks 14 and 16, respectively⁴

QUALITY
OF LIFE

QUALITY OF LIFE

Brella-treated patients experienced a significant physical and emotional improvement in quality of life⁵

SAHARA 7 Sweat Stressors: Negative Impact of Sweat on Daily Quality of Life (QoL) & Positive Impact of Brella™ at 4 and 12 Weeks

Before Brella Treatment

(Baseline)

4 weeks after Brella

(Brella patients improved)

12 weeks after Brella

(Brella patients improved)

Seven Questions from the SAHARA Clinical Study designed to assess the impact of sweating on both physical activities and psycho-social factors

How Brella® Works

Clinical Results

Treatment Overview

The Brella ProcedureEasy as 1, 2, 3!

Clean, Dry, and Apply1

Patch Application & Removal1

Deactivate and Dispose1

Sign up to learn more and to reserve your spot to add Brella® to your practice

References

Cart

How Brella® Works

Clinical Results

Treatment Overview

The Brella ProcedureEasy as 1, 2, 3!

Clean, Dry, and Apply1

Patch Application & Removal1

Deactivate and Dispose1